Biotech Pursuing COVID-19 Vaccine Inks $167M Acquisition
Novavax has agreed to buy Czech Republic-based Praha Vaccines for $167 million, and the duo will work with vaccine manufacturer Serum Institute of India to develop and mass produce a potential...To view the full article, register now.
Already a subscriber? Click here to view full article